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Group I metabotropic glutamate receptors are expressed in the
chicken retina and by cultured retinal amacrine cells
Kathryn M. Kreimborg,1 Martha L. Lester, Kathryn F. Medler2 and Evanna L. Gleason
Department of Biological Sciences, Louisiana State University, Baton Rouge, Louisiana, USA

Abstract
Glutamate is well established as an excitatory neurotransmitter in the vertebrate retina. Its role as a modulator of retinal
function, however, is poorly understood. We used immunocytochemistry and calcium imaging techniques to investigate
whether metabotropic glutamate receptors are expressed in
the chicken retina and by identi®ed GABAergic amacrine cells
in culture. Antibody labeling for both metabotropic glutamate
receptors 1 and 5 in the retina was consistent with their
expression by amacrine cells as well as by other retinal cell
types. In double-labeling experiments, most metabotropic
glutamate receptor 1-positive cell bodies in the inner nuclear
layer also label with anti-GABA antibodies. GABAergic
amacrine cells in culture were also labeled by metabotropic
glutamate receptor 1 and 5 antibodies. Metabotropic

glutamate receptor agonists elicited Ca21 elevations in
cultured amacrine cells, indicating that these receptors were
functionally expressed. Cytosolic Ca21 elevations were
enhanced by metabotropic glutamate receptor 1-selective
antagonists, suggesting that metabotropic glutamate receptor 1
activity might normally inhibit the Ca21 signaling activity of
metabotropic glutamate receptor 5. These results demonstrate expression of group I metabotropic glutamate receptors
in the avian retina and suggest that glutamate released from
bipolar cells onto amacrine cells might act to modulate the
function of these cells.
Keywords: amacrine cells, Ca21 imaging, chicken retina,
immunocytochemistry, metabotropic glutamate receptors.
J. Neurochem. (2001) 77, 452±465.

Glutamate is the primary excitatory neurotransmitter in the
vertebrate retina. It is released from photoreceptors onto
bipolar cells and horizontal cells in the outer plexiform layer
and from bipolar cells onto amacrine cells and ganglion cells
in the inner plexiform layer. The best characterized role of
glutamate at vertebrate central synapses is to activate
ionotropic glutamate receptors and depolarize the postsynaptic neuron. Glutamate can, however, also activate
metabotropic receptors (mGluRs), such as mGluR6 which
mediates the hyperpolarizing response of ON bipolar cells
(Nakajima et al. 1993; Masu et al. 1995; Vardi and
Morigiwa 1997; Vardi et al. 1998). Immunocytochemistry
and in situ hybridization studies in the mammalian retina
have demonstrated that other mGluRs are also expressed
throughout the retina (Hartveit et al. 1995; BrandstaÈtter
et al. 1996; Koulen et al. 1997; Vardi et al. 1998; Cai
and Pourcho 1999). How the activation of these other
mGluRs impacts retinal function is largely unknown.
Nonetheless, the expression of mGluRs at synapses that
also contain ionotropic glutamate receptors suggests that
glutamate can act as a modulator as well as an excitatory
neurotransmitter.

The mGluRs are a family of G protein-coupled receptors
linked to cytosolic second messenger systems. Eight
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members of this receptor gene family have been cloned to
date and have been divided into three groups based on
sequence similarities and pharmacological properties (for
review see Conn and Pin 1997). Group I mGluRs (mGluRs 1
and 5) are commonly linked to the phosphatidylinositol
pathway where receptor activation causes an increase in
cytosolic IP3, usually leading to mobilization of Ca21 from
intracellular stores as well as activation of protein kinase C.
Group I receptors can also stimulate the production of cyclic
AMP (Aramori and Nakanishi 1992 Joly et al. 1995;
McCool et al. 1998). Although they have different
pharmacological properties, groups II (mGluRs 2 and 3)
and III (mGluRs 4, 6, 7 and 8) are both linked to the cyclic
AMP cascade and have been shown to inhibit forskolinstimulated increases in cyclic AMP. Activation of any of
these receptors can lead to multiple cellular effects,
including alterations in the voltage response properties of
neurons (Wang and McCormick 1993; Godwin et al. 1996)
as well as changes in synaptic transmission (Baskys and
Malenka 1991; Hayashi et al. 1993; Poncer et al. 1995; Chu
and Hablitz 1998; Bushell et al. 1999; Vetter et al. 1999).
Our goal in this work was to begin to test the hypothesis
that glutamate can modulate the function of amacrine cells
by activating the group I mGluRs. To explore this
hypothesis, we employed a culture system consisting of
retinal neurons derived from the embryonic chicken retina.
GABAergic amacrine cells have been previously identi®ed
in these cultures on both immunocytochemical and physiological criteria (Huba and Hofmann 1990, 1991; Huba et al.
1992; Gleason et al. 1993). Although the GABAergic
amacrine cells are derived from embryonic retinas, they
acquire a mature phenotype in culture by several measures.
After 6 days in culture, they express the same compliment
of voltage- and ligand-gated ion channels as amacrine cells
in the mature chicken retina (Huba and Hofmann 1991;
Huba et al. 1992). After 7±8 days in culture, these cells also
form functional GABAergic synapses with each other
(Gleason et al. 1993); a synaptic interaction found in the
intact adult retina. Our ability to identify these cells coupled
with their formation of functional synapses makes this an
ideal system to ask how activation of mGluRs affects the
behavior of GABAergic amacrine cells.
To establish the relevance of this approach, we ®rst used
immunocytochemical methods to determine the expression
pattern of group I mGluRs in the adult chicken retina. We
then examined the expression of group I mGluRs by the
cells in culture. To demonstrate the functionality of the
mGluRs in culture, we used Ca21 imaging techniques to
measure agonist-induced changes in cytosolic Ca21 levels.
Our results demonstrate that group I metabotropic glutamate
receptors are expressed by GABAergic amacrine cells as
well as other cell types in the intact retina. Furthermore,
Ca21 imaging experiments demonstrate that these receptors
are functional in cultured GABAergic amacrine cells. These

results also suggest that Group I receptor subtypes may
interact with one another at the level of Ca21 signaling.
Experimental procedures
Materials
Polyclonal antibodies raised against mGluRs1 and ®ve were
purchased from Upstate Biochemicals (Lake Placid, NY, USA).
GABA antibodies were obtained from Sigma (St Louis, MO, USA).
All secondary antibodies were purchased from Chemicon
(Temecula, CA, USA). Fluo-3 acetoxymethylester (¯uo-3 AM)
was purchased from Molecular Probes (Eugene, OR, USA). The
mGluR agonists: (1S,3R)-1-aminocyclopentane-1,3-dicarboxylic
acid (ACPD), (RS)-2-chloro-5-hydroxyphenylglycine (CHPG),
(RS)-3,5-dihydroxyphenglycine (DHPG), and glutamate (Sigma)
and antagonists: (RS)-1-aminoindan-1,5-dicarboxylic acid (AIDA),
2-amino-5-phosphopentanioic acid (APV), 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX), and (S)-a-methyl-4-carboxyphenylglycine (MCPG) were obtained from Tocris Cookson (Ballwin, MO,
USA) unless otherwise indicated.
Cell culture
Dissociation and culture methods have been previously reported
(Gleason et al. 1992). Brie¯y, retinas from 8-day-old White
Leghorn chicken embryos (Gallus gallus domesticus, Poultry
Science Department, Louisiana State University, LA, USA) were
dissociated in 0.1% trypsin and plated at 5.0  105 cells/35 mm
tissue culture dish. Dishes were previously coated with 0.1 mg/mL
poly l-ornithine. Retinal cultures were maintained in Dulbecco's
modi®ed Eagle's medium (Gibco, Rockville, MD, USA) with 5%
fetal bovine serum (HyClone, Logan, UT, USA), 1000 U penicillin/
mL, 100 mg streptomycin/mL, and 1 mm l-glutamine (Sigma).
Time in culture is expressed as embryonic equivalent (EE) day.
Antibodies
Purchased polyclonal antibodies were raised in rabbits against
C-terminal peptide fragments of rat mGluRs 1 and 5. The peptide
sequence used to generate the mGluR1 antibody (KPNVTYASVILRDYKQSSSTL) is only found in the mGluR1a splice variant
(Pin et al. 1992). For the mGluR5 antibody, the peptide sequence
used (KSSPKYDTLIIRDYTNSSSSL) is present in both mGluR5a
and mGluR5b splice variants (Joly et al. 1995). GABA antibodies
were raised against GABA conjugated to bovine serum albumin
(BSA).
Western blots
Adult White Leghorn chickens were killed by cervical dislocation
and decapitated. Retinas and brain tissue were dissected and placed
on ice in phosphate-buffered saline (PBS) containing the following
protease inhibitors: phenylmethylsulfonyl ¯uoride 1.0 mm, aprotinin 0.1 mg/mL and leupeptin 10.0 mg/mL. Proteins were electrophoresed on a 6% sodium dodecyl sulfate±polyacrylamide gel
according to Laemmli (1970). After separation, proteins were
transferred to nitrocellulose membranes (transfer buffer: 25 mm
Tris, 192 mm glycine, 20% methanol, pH 8.3). Nitrocellulose
membranes were incubated for 30 min with blocking buffer (1%
bovine serum albumin, 5% normal goat serum, 0.1% Tween 20 in
Tris-buffered saline: 10 mm TrisHCl, 150 mm NaCl, pH 7.4) then
placed in primary antibody (mGluR1, 1 : 1000; mGluR5 1 : 2000,
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1 h, room temperature) followed by incubation at 24±278C with the
secondary antibody (1 : 1000, 1 h), a goat anti-rabbit Fab fragment
conjugated to horseradish peroxidase. Antibodies were visualized
using the Super Signal chemiluminescence kit (Pierce, Rockford,
IL, USA).
Immunocytochemistry
Eyes were enucleated and the anterior region of each eye and the
vitreous were removed. Eyecups were immediately immersed in
4% paraformaldehyde. Subsequent removal of the retinas from
eyecups was done in the presence of ®xative. Retinas remained in
®xative for 3 h at 48C then left overnight in 20% sucrose at 48C.
Vertical sections (10±12 mm) were cut from peripheral as well as
central retina and our results were the same for both regions. Cultured
cells were ®xed in 2% paraformaldehyde in PBS for 1 h at 48C.
All antibody experiments on adult chicken sections were
repeated at least two times on sections cut from samples from
each of four different animals. Retinal sections were incubated
for 2 h in 5% normal goat serum in dilution solution (1% BSA,
0.5% saponin in PBS). Appropriate antibody dilutions were
determined on retinal sections by examining dilutions ranging
from 1 : 500 to 1 : 5000 with the optimal range for each of the
antibodies falling between 1 : 500 and 1 : 1000. Primary antibodies were applied for either 2 h at room temperature (24±278C)
or overnight at 48C. Goat anti-rabbit secondary antibodies
conjugated to Cy3 were diluted in dilution solution and applied
at 1 : 1000 for 1±2 h at room temperature then rinsed in PBS.
Double labeling of sections was attempted for the mGluR1/GABA
combination as well as the mGluR5/GABA combination. The
mGluR5/GABA combination showed evidence of cross-talk of
secondary antibodies regardless of the order of primary antibody
application. Successful double labeling of sections with the
mGluR1/GABA combination was achieved by serial application
of anti-mGluR1 followed by Cy3-labeled goat anti-rabbit
secondary, then anti-GABA (1 : 800) followed by ¯uorescein
isothiocyanate (FITC)-labeled goat anti-rabbit secondary (1 : 500).
When anti-GABA antibodies and secondary were applied before
anti-mGluR1 antibodies and secondary, cross-labeling by secondary antibodies was observed suggesting that binding sites on antiGABA antibodies were not saturated by the ®rst secondary
antibody application. Higher secondary antibody concentrations
generated background labeling in secondary-only controls, so this
strategy was abandoned. For the mGluR1/GABA combination of
antibodies, reversing the order of antibody applications eliminated
the cross-labeling.
To analyze double labeling of sections, image pairs were scanned
into Adobe Photoshop (San Jose, CA, USA), pseudo-colored and
brought into register using multiple landmarks. Labeled cell bodies
were scored as double-labeled, single-labeled by anti-mGluR1 or
single-labeled by anti-GABA.
For antibody experiments on cultured cells, primary antibodies
against mGluR1 and mGluR5 and secondary Cy3-conjugated goat
anti-rabbit antibodies were all used at 1 : 1000 for 1 h at room
temperature. Each antibody was tested on cultured cells ®xed on EE
12, 14, 16 and 18. All experiments on cultured cells were
performed at least three times on different primary cultures.
Retinal sections and cultured cells were viewed on an Olympus
IX70 inverted microscope. To visualize Cy3 labeling, 510±550 nm
excitation and 590 nm emission ®lters were used. For double

labeling, FITC was visualized with a 450±480 nm excitation ®lter
and a 515±545 nm band pass emission ®lter was used to eliminate
the bleed through from the Cy3 signal into the FITC channel. Both
sections and cultured cells were photographed using Kodak Tmax
400 ®lm (Rochester, NY, USA). Micrographs were scanned then
assembled into ®gures using Adobe Photoshop.
Calcium imaging
Cultured cells (EE 15±17) were loaded with 2 mm ¯uo-3 AM in
Hank's balanced salt solution for 1 h at room temperature and in
the dark. At the end of the loading period the cells were washed
with normal external solution (see below) and maintained in
darkness until they were used, routinely within 20 min. Culture
dishes were mounted on the stage of an upright Nikon Optiphot II
microscope (Melville, NY, USA) and the cells imaged with a Noran
laser confocal imaging system (Middleton, WI, USA) through a
40  water immersion objective. The 488 nm laser line with a
515-nm long pass ®lter were used to obtain the ¯uorescence signal.
Image and data acquisition were controlled by the InterVision
(Noran) software and hardware packages. The shutter was opened
only every 3 or 5 s (for 1.5 s) to minimize the exposure of the cells
to the laser. During shutter openings eight images were collected
and averaged. Mean pixel intensity was sampled over a rectangular
region of the cell body (approximately 25 mm2 at 28 Hz). Peak
pixel intensity values collected during shutter openings were
subsequently extracted from the raw data using the `pick peaks'
routine from the Origin software package (Microcal, Northampton,
MA, USA). This method employs a sliding window to identify
peaks (data collected during shutter openings) in the data which
were subsequently con®rmed by eye. Background ¯uorescence was
sampled from a cell- and process-free region of the ®eld and
remained constant over the duration of the experiments. Data are
expressed as the change in ¯uorescence intensity over baseline
¯uorescence (F/F). All comparisons of response amplitude were
made pairwise from data collected in the same cell.
Solutions were delivered by gravity-driven bath perfusion
(3±4 mL/min) with a 1-mm inlet positioned about 2±3 mm
upstream from the cells. Solution changes were achieved by
manual operation of pinch clamps. For consistency, the timing of
solution changes was manually synchronized with shutter openings.
Approximately 14 s of the delay between agonist application and
the cellular response was due to dead space in the perfusion line.
The composition of the normal external solution was (in mm)
KCl, 5.3; NaCl, 135.0; CaCl2, 3.0; MgCl2, 0.41; glucose, 5.6;
and HEPES, 3.0; pH 7.6. CHPG, AIDA and MCPG stocks
(50±100 mm) were made in 0.1 m NaOH, diluted to their ®nal
concentration in normal external solution and the pH adjusted to
7.6. Other compounds were ®rst diluted in water (50±100 mm) then
added to the normal external solution. All reagents were prepared
fresh the day of the experiment.

Results
Antibody speci®city
Because the mGluR antibodies were generated against
mGluR peptide fragments from the rat, we performed
western blot analysis to determine whether these antibodies
would recognize a protein of the appropriate molecular
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Fig. 1 Antibodies detected proteins of the appropriate molecular
weight in chicken brain and retina. Antibodies raised against
mGluR1 and mGluR5 peptide sequences from rat receptors were
incubated with a blot of proteins from a homogenate of adult chicken
brain and retina. Fifty micrograms of protein was loaded onto each
lane. For mGluR1, the major band was labeled at an approximate
molecular weight of 147 kDa (arrow). The mGluR5 antibody labeled
a single band at about 154 kDa (arrow).

weight in the chicken. The deduced molecular weight for rat
mGluR1a (see Experimental procedures) is approximately
133 kDa (Masu et al. 1991) and the mGluR1 antibody
recognizes a protein from rat brain tissue at 142 kDa
(Martin et al. 1992). The deduced molecular weight for rat
mGluR5a is approximately 128 kDa (Abe et al. 1992) and
this mGluR5 antibody recognizes the rat mGluR5a
expressed in Xenopus oocytes at 150 kDa (Gereau and
Heinemann 1998). In our adult chicken brain and retinal
homogenates, both anti-mGluR1 and anti-mGluR5 antibodies bound a distinct band of an appropriate molecular
weight, approximately 147 kDa for mGluR1 and 154 kDa
for mGluR5 (Fig. 1). Labeled, high molecular weight
material may represent labeling of dimerized receptors
(Pin et al. 1992). For the anti-mGluR1 antibody, an
additional faint band was visible at the 97 kDa marker,
possibly a degradation product. No other lower molecular
weight labeling was seen for these two antibodies. These
results indicate that the antibodies recognize mGluRs 1 and
5 from the chicken. Controls for non-speci®c binding of
secondary antibodies in immunocytochemistry experiments
showed little, if any background labeling (Fig. 2). Sections
incubated with pre-immune goat serum but neither
primary nor secondary antibodies showed only the auto¯uorescence of outer segments and oil droplets also seen
in the secondary-only controls (not shown). In both types
of controls, the degree of auto¯uorescence from the
outer segments was quite variable (compare Fig. 7b and d)

Fig. 2 Secondary antibodies alone did not label intact or cultured
retina. (a) and (b), The Nomarski and corresponding ¯uorescent
image illustrate that application of the goat anti-rabbit secondary
antibody alone did not label retinal sections. Auto¯uorescence of
photoreceptor outer segment fragments and oil droplets was
observed. (c) and (d), Phase and ¯uorescent images of a representative ®eld of cultured EE 16 retinal cells incubated with secondary
antibody only. Scale bars, 50 mm.

and this was due to differences in the amount of
outer segment material that survived dissection and
sectioning.
Group I mGluR immunoreactivity in intact retina
The mGluR1 antibody labeled multiple layers in the adult
chicken retina (Fig. 3). Photoreceptors were labeled at the
level of the inner segments. Just below this, a dashed pattern
of labeling was observed that may correspond to photoreceptor terminals. Additional labeling was detected at the
outer plexiform layer (OPL) which could arise from labeling
of bipolar cell dendrites, horizontal cell processes, or some
combination of these. It was dif®cult to discern whether
horizontal cell bodies were labeled and contiguous with
processes in the OPL (but see below). Labeled cell bodies
were observed scattered throughout the INL but immunoreactivity was consistently detected in cells in the inner onethird of the INL, and a subset of more intensely labeled cell
bodies were often observed near the inner border of the INL
(Fig. 3a and c). When intensely labeled cell bodies were
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Fig. 3 Anti-mGluR1 labels cell bodies as well as processes in the
adult chicken retina. (a) and (b), Labeling is evident in photoreceptor
inner segments and what appear to be photoreceptor terminals
(small arrows) as well as other elements the outer plexiform layer
(OPL). Cell bodies primarily in the inner one-third of the inner
nuclear layer (INL) are labeled, and a subset of cell bodies are more
intensely labeled (arrows). Five discrete bands of labeling are also

seen in the inner plexiform layer (IPL). Cells in the ganglion cell
layer (GCL single arrowhead) as well as axons, are also labeled. (c)
A higher magni®cation view of a different section shows a brightly
labeled cell near the inner border of the INL that has a process
extending laterally (arrowheads) into the outer layer of the IPL.
Scale bars are 50 mm.

seen, laterally oriented processes in the outer-most region of
the inner plexiform layer (IPL) could sometimes be
observed (Fig. 3c). The lateral orientation of labeled
processes and the location of the cell bodies suggests that
these intensely labeled cells are amacrine cells. In the IPL,
®ve distinct layers of labeling were observed (Fig. 3a). The
IPL labeling occured in both OFF and ON sublaminae
suggesting participation in both pathways. Virtually all cell
bodies in the ganglion cell layer (GCL) were labeled, and
labeling in ganglion cell axons was faint but detectable. This
observation suggests that both ganglion cells and displaced
amacrine cells express mGluR1.
The binding of mGluR5 antibodies was widespread in
sections of adult chicken retina (Fig. 4a). Photoreceptors
were labeled at the level of the inner segments and in the
OPL, brightly labeled processes could occasionally be seen
to arise from cell bodies at the outer border of the INL
(Fig. 4c), indicating horizontal cell labeling. Labeled cell
bodies were distributed throughout the INL indicating that
horizontal cells, bipolar cells, MuÈller cells and amacrine
cells may all express mGluR5. A subset of more heavily
labeled cell bodies located at the innermost border of the
INL were occasionally observed (Fig. 4a). In the IPL, four
bands of labeling were apparent and, as for mGluR1,
included both the OFF and ON sublaminae. A subset of cell
bodies in the ganglion cell layer, as well as axons, were also
labeled. Although a large fraction of retinal cells were
labeled by anti-mGluR5, three pieces of evidence indicate
that binding of the mGluR5 antibody was speci®c. First, we
tested primary antibody dilutions ranging from 1 : 500 to
1 : 5000 and at higher dilutions, all of the labeling dropped
out at the same dilution (1 : 4000±5000). Second, the

banding pattern in the IPL indicates that the antibody only
labels a subset of processes. Finally, our western blot
samples contained retina and no non-speci®c binding was
detected for anti-mGluR5 with this method (Fig. 1). Taken
together, these results imply that group I mGluR expression
is extensive in the chicken retina and plays a role in
processing information in both OFF and ON pathways.
Furthermore, the labeling pattern with both antibodies is
consistent with the hypothesis that amacrine cells can
express both of these receptors.
Group I mGluR immunoreactivity in cultured retinal
cells
Several cell types can be identi®ed in retinal cultures
derived from the embryonic chicken including cone
photoreceptors (Adler et al. 1984; Gleason et al. 1992),
bipolar cells (Gleason and Wilson, unpublished data),
amacrine cells (see below) and MuÈller glial cells (Combes
et al. 1977; Adler et al. 1982; Hyndman and Adler 1982).
Horizontal cells have not yet been identi®ed in culture (but
see below) and ganglion cells do not survive in culture in the
absence of target-derived growth factors (Nurcombe and
Bennett 1981; Vanselow et al. 1990). Amacrine cells have
been identi®ed based on both immunological and numerous
physiological criteria (Huba and Hofmann 1990; Huba et al.
1992; Gleason et al. 1993). These amacrine cells have
relatively large (10±15 mm) cell bodies with multiple
processes and immunocytochemical and physiological
evidence demonstrates that these cells are functionally
GABAergic (Gleason et al. 1993). In the intact retina,
different classes of amacrine cells employ different
neurotransmitters such as GABA, glycine, acetylcholine
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Fig. 4 Anti-mGluR5 labeling is found in all layers of the adult
chicken retina. (a) and (b), Photoreceptor inner segments are
labeled and additional intense labeling is found in the OPL. Labeling
is seen throughout the INL, with a brightly labeled soma at the inner
border of the INL (arrow). The labeling within the IPL is found in four
bands. Labeling is also seen in cells in the GCL (arrowheads) and in
ganglion cell axons. (c) and (d), Fluorescence and Nomarski images
of a region of the OPL and INL in a tangential section. The labeled
cell body is positioned at the outer border of the INL (arrow) and
extends processes laterally and upward into the OPL, indicating that
this is a horizontal cell. Scale bars are 50 mm.

and dopamine. So, on this criterion, the population of
amacrine cells in culture represents just one of the possible
amacrine cell phenotypes.
In these cultures all neurons, including cone photoreceptors (not shown) labeled with the mGluR1 antibody. The
vast majority of neurons labeled lightly but distinctly above
controls at all times examined (Fig. 5). A subset of amacrine
cells, however, were more intensely labeled. For these cells,
mGluR 1 expression was found on cell bodies and was just
visible on processes as early as EE 12 (Figs 5a and b). Over
time in culture, the fraction of amacrine cells that were more
intensely labeled increased as did their degree of labeling.
These relatively brightly labeled amacrine cells were
extremely rare until EE 16, however, even at EE 18, the

Fig. 5 The expression pattern of mGluR1 in cultured amacrine cells
changes over time. (a) and (b), Representative phase and ¯uorescent images of EE 12 amacrine cells. All cell bodies are lightly
labeled with mGluR1 and labeling is just detectable in the processes
connecting two of the cells (arrows). (c) and (d), Representative
phase and ¯uorescent images of a strongly labeled amacrine cell in
an EE 16 culture. The entire amacrine cell, including processes is
labeled but the underlying glial cell shows little, if any, labeling.
Scale bars are 50 mm.

fraction of relatively heavily labeled amacrine cells was still
less than 5% of the total population of amacrine cells. Because
there is little, if any, cell division among the neuronal cells in
culture (Gleason and Wilson, unpublished observations) we
interpret this observation to indicate that expression levels
are increasing over time in a subset of amacrine cells. Glial
cells were not labeled by the mGluR1 antibody.
The mGluR5 antibody strongly labeled all neurons in
culture, with some variation in labeling intensity evident
from cell to cell (Fig. 6). Labeling in neurons was found
throughout the cell, including neuronal growth cones. No
changes in either the pattern or the intensity of labeling were
detected from EE 12 through EE 18. Interestingly, the most
intensely labeled neurons were always of a distinctive
anatomical class. These cells had a near-radial array of
short, stout processes (Figs 6a and b). Because the horizontal

q 2001 International Society for Neurochemistry, Journal of Neurochemistry, 77, 452±465

458 K. M. Kreimborg et al.

Fig. 6 mGluR5 is expressed by cultured amacrine cells between EE
12 and EE 18. (a) and (b), Phase and ¯uorescent micrographs of an
EE 16 culture showing the expression of mGluR5 in one amacrine
cell (asterisk) and two other cells of a distinct morphological class
(arrows). These cells are nearly of radial symmetry, bear relatively
short processes, and consistently show a higher level of labeling
than the amacrine cells. (c) and (d), This ®eld contains EE 14 amacrine cells (asterisks) labeled over their cell bodies and processes.
Intense labeling can be seen at varicosities of larger processes
(arrowheads) and at a point of contact (arrow) between two amacrine cells (center and lower left). At the top of the ®eld is a labeled
growth cone. Glial cells were labeled by the mGluR5 antibody (small
arrow) in a punctate pattern. Scale bars are 50 mm.

cell processes contributed to the most intensely labeled
feature of the adult retina (Figs 4a and c), we suggest that
this strongly labeled subset of cells in culture might be
horizontal cells. Con®rmation of this identi®cation will,
however, require an examination of the physiological
properties of these cells. We also found mGluR5 labeling
in glia where the labeling was clearly punctate (Fig. 6d).
Group I mGluR and GABA double-labeling in retinal
sections
Because mGluRs 1 and 5 are highly expressed in the intact
retina and because antibodies against these receptors label

GABAergic amacrine cells in culture, we asked whether the
labeling pattern of mGluR antibodies overlapped with
expression of GABA by amacrine cells in the intact retina.
We used a polyclonal antibody raised against GABA in
combination with either anti-mGluR1 or 5. Our attempts to
double label sections with the anti-mGluR5 and anti-GABA
antibodies were not successful (see Experimental procedures). For double labeling with anti-mGluR1 and antiGABA (Fig. 7), the labeling patterns were the same
regardless of whether we single-labeled (anti-mGluR1
only, Fig. 7a; anti-GABA only, Fig. 7b) or double-labeled
(anti-mGluR1 and anti-GABA, Fig. 7c and d) the sections,
con®rming that the overlap in the ¯uorescence signal was
not due to an artifact. The pattern of anti-GABA labeling,
both alone and in double-labeled sections was similar to that
previously reported for the chicken retina (Mosinger et al.
1986; Kalloniatis and Fletcher 1993) with two exceptions. In
the ®rst, a more distinctive banding pattern was sometimes
observed in the IPL rather than that described previously
(Kalloniatis and Fletcher 1993). The banding was less
intense when samples were ®xed more quickly (®xation
prior to dissection) so we attribute the appearance of bands
of GABA immunoreactivity to the partial loss of GABA that
occured during the ®xation process. Another difference was
that we observed binding of anti-GABA antibodies on
the photoreceptor side of the OPL, primarily at the level of
photoreceptor terminals. This was unexpected because
photoreceptors are known to be glutamatergic. This labeling
may be an artifact from non-speci®c binding of the antiGABA antibody or may represent a metabolic pool of
GABA. Alternatively, the appearance of labeling may arise
from invaginating GABAergic horizontal cell processes
(Araki and Kimura 1991). As expected, anti-GABA labeling
was strong in the OPL, with processes connecting to
horizontal cell bodies, at the outer margin of the INL.
Analysis of the overlap in anti-GABA and anti-mGluR1
labeling helped to resolve the question of mGluR1
expression by horizontal cells. Although the anti-GABA
labeled elements are more easily distinguishable as
horizontal cell bodies, we found that mGluR1 labeling just
proximal to the OPL consistently overlapped with antiGABA labeled horizontal cell bodies. This observation
con®rms that mGluR1 is expressed by horizontal cells.
Interestingly, horizontal cell processes form a very bright
band of GABA immunoreactivity in the OPL but a gap in
mGluR1 labeling is often discernable in this region (Fig. 7,
compare c and d). This observation implies that some
horizontal cell processes do not bear mGluR1 receptors.
In the INL and GCL, the labeling patterns for the mGluR1
and GABA antibodies were very similar. Both antibodies
labeled cells in the inner one-third of the INL. In Fig. 7(c
and d), ®ve examples of double-labeled cell bodies in the
INL are indicated with arrows. To more quantitatively
explore the fraction of double-labeled cells in the inner INL,
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Fig. 7 GABA and mGluR1 are colocalized in amacrine cells. (a)
and (b), Sections singly labeled with either anti-mGluR1 (a) or antiGABA antibodies (b). (a) The typical anti-mGluR1 labeling pattern is
seen with some photoreceptor and OPL labeling, a subset of brightly
labeled cell bodies in the INL, ®ve discrete bands of label in the IPL
and labeled cell bodies in the GCL. (b) Anti-GABA labeling is
strongest in the OPL and in cells (presumably horizontal cells) at the
outer border of the INL. Just as with mGluR1, labeling is seen in
cells in the inner one-third of the INL, in the IPL and on cell
bodies of the GCL. The bright ¯uorescence along the top of the
section in (b) is due to the survival of an unusually large fraction of

auto¯uorescent outer segments that folded back onto themselves.
The panel to the right in (b) shows a control section from the same
block of tissue that was not exposed to either the primary or
secondary antibody. (c) and (d), A section of adult retina double
labeled with antibodies against mGluR1 and GABA, respectively.
The image in (d) has been ¯ipped horizontally to produce a mirror
image of (c). Five double-labeled cell bodies in the INL are indicated
(arrows) and one cell that was labeled with the mGluR1 antibody
only is denoted with an asterisk. Three examples of double-labeled
cells in the GCL are also indicated (arrowheads). Scale bars are
50 mm.

pairs of images from ®ve double-labeled retinal sections
were overlapped and aligned. All elements that could clearly
be distinguished as cell bodies were inspected for double
labeling. Out of 178 cells analyzed, 79% labeled with both
antibodies, 13% labeled with the mGluR1 antibody only,
and 8% labeled with the GABA antibody only. This analysis
suggests that the vast majority of GABAergic amacrine cells
also express mGluR1.
In the GCL, virtually all discernable cell bodies were both
mGluR1- and GABA-positive. The GABA-positive cells in
the GCL and the labeling of axons indicates that at least
some of the labeled cells are ganglion cells. Ganglion cells
are known to be functionally glutamatergic, so the GABA

antibodies may be reporting GABA leaked through gap
junctions from coupled GABAergic amacrine cells (Jacoby
et al. 1996; Xin and Bloom®eld 1997). Mosinger et al.
(1986) and Kalloniatis and Fletcher (1993) also report
labeling of ganglion cells with anti-GABA antibodies in the
chicken retina.
Functional analysis of amacrine cell mGluRs
Our antibody experiments on cultured amacrine cells
indicate that these cells express mGluRs 1 and 5. Proper
function of these receptors requires that they be expressed
on the plasma membrane and that the transduction and
signaling mechanisms subserving their effects also be
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Fig. 8 Activation mGluRs can elevate cytosolic Ca21 concentration.
Fluorescence from the Ca21 indicator ¯uo-3 is plotted against time
for a representative cultured amacrine cell. For this experiment, an
image was collected every 5 s. The ionotropic glutamate receptor
blockers CNQX (100 mM) and APV (100 mM) were applied over the
time depicted by the bar. Glutamate (30 mM) was applied for 20 s at
the time indicated by the arrow.

expressed. Group I mGluRs are usually linked to the IP3
pathway which modulates cytosolic Ca21 concentrations. In
order to discover whether these receptors are in the plasma
membrane and are functionally linked to this signaling
machinery, we asked whether agonists for group I mGluRs
would generate Ca21 elevations in cultured amacrine cells.
To detect Ca21 elevations, we loaded cells (EE 15±EE 17)
with the Ca21 indicator ¯uo-3 AM and monitored their
¯uorescence intensity before, during and after agonist
application using laser scanning confocal microscopy. We
®rst examined the effects of glutamate, the presumed
endogenous agonist. Because these cells also express
ionotropic glutamate receptors (Huba and Hofmann 1991),
we used APV (100 mm) to block NMDA receptors and
CNQX (100 mm) to block non-NMDA receptors. Voltage
clamp experiments show that at these concentrations the
blockers completely suppress glutamate (30±100 mm)-gated
inward currents in amacrine cells (Sosa and Gleason,
unpublished data). Fifty-six percent of amacrine cells
stimulated with glutamate responded with a Ca21 elevation
(n  16, Fig. 8). Although amacrine cells are known to
form functional synapses in culture (Gleason et al. 1993),
we are con®dent that the Ca21 elevations we measured are
the direct result of activating mGluRs on individual
amacrine cells and are not due to excitatory interactions

Fig. 9 An mGluR5-speci®c agonist is the
most effective in elevating cytosolic Ca21.
(a) Data is shown for a representative
amacrine cell. An image was collected
every 3 s. ACPD (300 mM, arrow) applied
for 18 s elicited little, if any, change in cytosolic Ca21. However, when this same cell
was exposed to 100 mM DHPG, a much
larger elevation in cytosolic Ca21 was produced. (b) The mean changes in relative
¯uorescence are shown for cells exposed to
both ACPD and DHPG and that responded
to DHPG (n  9). The asterisk denotes
statistical signi®cance (p , 0.05). (c) Data
from a different amacrine cell is shown. At
the arrow, the cell was exposed to DHPG
(100 mM) for 30 s. Subsequently, the cell
was exposed to a 30 second pulse of
CHPG (100 mM) and a second, much larger
response is elicited. (d) Mean values for
relative changes in ¯uorescence are plotted
for six cells exposed to both agonists
(p , 0.05). Data plotted in (b) and (d) were
analyzed using the paired t-test.
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Fig. 10 Inhibition of mGluR1 enhances
cytosolic Ca21 elevations produced by
Group I agonists. (a) Data from a single
amacrine cell with images collected at 3-s
intervals. Initial application of 100 mM DHPG
(15 s, application starting at the arrow)
elicited no change in ¯uorescence intensity.
Another 15-s pulse of DHPG (arrow) delivered in the presence the group I antagonist
MCPG (500 mM, bar) results in an increase
in cytosolic Ca21. (b) Data is plotted for
nine cells and shows a statistically signi®cant (p , 0.05) enhancement of the
response by MCPG. (c) Data from another
amacrine cell where initial exposure to
CHPG (100 mM, 30 s starting at arrow) produces a small change in ¯uorescence intensity. Co-application of the mGluR1-speci®c
antagonist AIDA (200 mM) enhances the
response to CHPG. (d) Mean changes in
¯uorescence intensity are plotted for 17
cells and show that AIDA signi®cantly
(p , 0.01) enhances the Ca21 elevation
produced in response to CHPG. Data in (b)
and (d) were analyzed using the paired
t-test.

between cells. First, responses with the similar time courses
can be found in both isolated amacrine cells and connected
amacrine cells. Second, a physiological and pharmacological analysis of the synapses between amacrine cells in
culture has demonstrated that they are mediated by GABAA
receptors and furthermore, that activity at these synapses
hyperpolarizes post-synaptic cells (Gleason et al. 1993).
We also examined the effects of an agonist speci®c for
group I mGluRs. DHPG activates both mGluRs 1 and 5 and
in an initial set of experiments we observed Ca21 responses
in 62% of amacrine cells examined (100 mm, n  26). We
observed considerable variability in the time courses of the
Ca21 elevations and this was independent of the age of the
cells and the agonist used. Additionally, there was also cell
to cell variability in the relative amplitudes of responses to
DHPG as well as the other agonists described below. The
relevance of these differences is not clear but we can say
that the magnitude responses was not correlated with
amacrine cell shape (which might indicate different
amacrine cell subtypes) nor with the age of the cells. As
such, all of our comparisons of relative response amplitudes
are taken from data collected in the same cell.
Duarte et al. (1996) reported that the group I and II
agonist ACPD (200 mm) stimulates hydrolysis of inositol
phospholipid but not Ca21 elevations in chick retinal

cultures. In contrast, we ®nd that activation of group I
mGluRs can produce cytosolic Ca21 elevations. To address
this discrepency, cells were tested for responsiveness to both
ACPD and DHPG. For these experiments, 100 mm DHPG
and 300 mm ACPD was used. These concentrations are
17±50 (DHPG) and 30±60 (ACPD) times the EC50 values
reported for group I receptors from the rat (Schoepp et al.
1999). Out of nine cells which responded to DHPG, six also
responded to ACPD, but these responses were small relative
to the Ca21 elevations produced by DHPG (Fig. 9a and b).
The relative effectiveness of the two agonists was
independent of agonist order (not shown). Because DHPG
is more speci®c than ACPD, one interpretation of this result
is that the outcome of coactivation of multiple mGluRs is
attenuation of the Ca21 elevation. Whether the group II
receptors (mGluRs 2 and 3) are expressed by cultured
amacrine cells is unknown but immunocytochemical
evidence presented here indicates that both mGluRs 1 and
5 are expressed. To test the hypothesis that group I receptors
might inhibit each other when they are coactivated, we
compared the response amplitudes of cells stimulated with
both DHPG (100 mm) and CHPG (100 mm) an mGluR5selective agonist (Doherty et al. 1997). In all cells tested,
CHPG elicited a larger increase in cytosolic Ca21 than
DHPG (Fig. 9c and d; n  6). Because DHPG activates
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both mGluR1 and mGluR5, but CHPG is highly selective
for mGluR5, this result suggested that mGluR1 might
normally inhibit mGluR5. Overall, agonists that activate
multiple receptor subtypes (glutamate, ACPD and DHPG)
only elicited responses in a fraction of amacrine cells (52%,
30% and 62%, respectively), whereas the mGluR5-speci®c
agonist, CHPG was effective in eliciting Ca21 elevations in
100% of cells examined (n  23). It seemed unlikely that
these results were simply due to different ef®cacies of the
agonists because we were using a concentration of CHPG
that is about one-seventh of the IC50 values reported for
mGluR5 from the rat (Schoepp et al. 1999).
Further support of the possibility of inhibitory receptor
interactions comes from experiments pairing mGluR
antagonists with mGluR agonists. If mGluR1 inhibits
mGluR5 in cultured amacrine cells, then we would expect
that antagonists of mGluR1 would enhance responses to
DHPG. MCPG is a group I and II antagonist that is generally
more selective for mGluR1 than mGluR5 (Schoepp et al.
1999) and has been shown to have no effect on some
mGluR5 splice variants (Joly et al. 1995). In six out of nine
cells examined, DHPG responses either appeared (Fig. 10a),
or were enhanced in the presence of 500 mm MCPG. This
result is consistent with inhibitory interactions among
mGluRs. It has been demonstrated in other systems that
mGluR1 can have basal activity in the absence of ligand
(Joly et al. 1995; Prezeau et al. 1996). To test whether this
basal activity might normally have some inhibitory effect on
mGluR5, the effectiveness of CHPG was examined in the
presence of the mGluR1 speci®c blocker AIDA (Moroni
et al. 1997). When AIDA was combined with CHPG, it
always enhanced the amplitude of the CHPG-dependent
cytosolic Ca21 elevations (n  17, Figs 10c and d). In a
subset of cells the Ca21 elevations were relatively brief so
that recovery could also be examined and in all cases
(n  7), subsequent responses to CHPG alone were similar
in amplitude to the ®rst CHPG responses elicited (Fig. 10c).
These results suggest that basal mGluR1 activity might
normally function to limit the ability of activated mGluR5 to
produce Ca21 elevations.
Discussion
Group I mGluR expression by amacrine cells in the
intact retina
Our primary objective was to determine whether group I
mGluRs are expressed by amacrine cells. Our results
showing labeling of cell bodies in the inner one-third of
the INL are consistent with the possibility that amacrine
cells in the chicken retina express both mGluRs 1 and 5.
Although we have good evidence that most of these cells are
amacrine cells, it should be noted that displaced ganglion
cells can also be found in this region of the INL (Prada et al.

1989). We also observed that for both the mGluR1 and
mGluR5 antibodies, the intensity of labeling of cell bodies
in the INL was variable. Nonetheless, even a relatively low
level of labeling is probably functionally signi®cant because
the signaling of G protein-coupled receptors is ampli®ed by
association with second messenger systems. The colocalization of GABA and mGluR1 in cell bodies of both the INL
and GCL provides additional evidence that most of the cells
expressing mGluR1 are GABAergic amacrine cells.
In the cat, mGluR1a has been found in amacrine cells (Cai
and Pourcho 1999). In the rat retina, mRNA speci®c for
mGluR 1, but not 5, was localized to amacrine cells
(Hartveit et al. 1995). Immuno-electron microscopy, however, revealed that the mGluR5a protein is localized to
amacrine cell processes post-synaptic to bipolar cell
terminals (Koulen et al. 1997). The speci®c bands of IPL
labeling by anti-mGluRs 1 and 5 is consistent with
expression on amacrine cell processes, however, cellspeci®c localization of these receptors in the IPL must be
con®rmed in the transmission electron microscope.
Cell bodies in the ganglion cell layer were labeled by both
anti-mGluRs 1 and 5 with mGluR1 labeling virtually all
cells in the GCL while mGluR5 labeled only a subset. In the
rat retina, expression of mGluR1 was found in all cells of the
GCL (Hartveit et al. 1995) and in the cat retina, mGluR1a
was found both in displaced amacrine cells and in ganglion
cells (Cai and Pourcho 1999). In the rat, consistent with our
results, only a subset of cell bodies in the GCL expressed
mGluR5 mRNA (Hartveit et al. 1995). The results of our
double-labeling experiments with anti-GABA and antimGluR1 indicate that the mGluR1-positive cells in the
GCL also contain GABA. As previously discussed, axonal
labeling by anti-GABA antibodies indicates that some of the
labeled cells were ganglion cells. However, because it is
known that in the chicken retina, GABAergic amacrine cells
also reside in the GCL (Brandon 1985; Mosinger et al. 1986;
Kalloniatis and Fletcher 1993), we conclude that some
displaced amacrine cells are expressing mGluR1.
Group I mGluR expression by other cells in the intact
retina
We consistently found that anti-mGluRs 1 and 5 labeled the
inner segments and possibly the terminals of photoreceptors.
In the cat retina, expression of mGluR 1a has been found in
photoreceptors where it was localized to rod spherules (Cai
and Pourcho 1999). Expression of these mGluRs has not
been found for rat photoreceptors in immunocytochemical
(BrandstaÈtter et al. 1996; Koulen et al. 1997) or in situ
hybridization (Hartveit et al. 1995) studies. The difference
between rat and chicken may in part stem from the relatively
high fraction of cone cells in the chicken retina and cone
photoreceptors may express these mGluRs. A hypothesis
supported by our observation that labeled photoreceptors
often contain oil droplets, a characteristic of avian cone
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cells. It was not possible to quantify this, however, because a
large fraction of oil droplets are routinely lost during
dissection and sectioning. Nonetheless, the localization of
these mGluRs on the inner part of the photoreceptors
implies that they may serve an auto-receptor function.
Horizontal cells were labeled with both mGluR1 and
mGluR5 antibodies. With the mGluR5 antibody, processes
reaching up into the OPL were intensely labeled, however,
labeling of contiguous horizontal cell bodies was only
occasionally discernable. This agrees with the dendritic
localization of mGluR5 seen in acutely dissociated horizontal cells isolated from the cat®sh (Gafka et al. 1999). In
the rat retina, in situ hybridization studies have shown that
horizontal cells express mGluR5 mRNA (Hartveit et al.
1995) but antibodies raised against mGluR5a speci®cally
did not label horizontal cells in this same preparation
(Koulen et al. 1997). These results are not entirely
incompatible, however, because rat horizontal cells may
express the mGluR5b form of the protein and both isoforms
of the protein can be recognized by the mGluR5 antibody
used in our experiments (see Experimental procedures). Our
observation of mGluR1 and 5 expression by horizontal cells,
as supported by physiological evidence from the tiger
salamander retina, suggests that Group I mGluRs are
functionally expressed by horizontal cells (Yang and Wu
1991). Our results in the chicken imply that glutamate
released from photoreceptors not only depolarizes horizontal
cells but can also modulate their function.
The mGluR1 antibody primarily labeled cell bodies in
inner one-third of the INL but labeled cell bodies at all
levels of the INL could be detected implying that a relatively
small subset of bipolar cells might also express this receptor.
In the rat, mGluR1a has been localized to bipolar cell
dendrites and putative bipolar cell bodies (Koulen et al.
1997). Because the antibody against mGluR5 labels cell
bodies throughout the INL, we presume that at least some
bipolar cell bodies can express these receptors. In the rat
retina, mRNA for mGluR5 is expressed by a small
population of bipolar cells (Hartveit et al. 1995) and the
mGluR5a protein has been immuno-localized to rod bipolar
cell dendrites as well as terminals (Koulen et al. 1997). In
the chicken retina, we have identi®ed at least some of the
intensely labeled OPL processes as belonging to horizontal
cells but the possibility remains that this receptor is also
localized to bipolar cell dendrites.
Comparison between expression patterns in the intact
and cultured retina
Although we are primarily interested in the expression of the
group I mGluRs by GABAergic amacrine cells, it is
worthwhile to consider whether the embryonic dissociation
and development in the culture dish signi®cantly alters the
expression of group I mGluRs in general. For the mGluR1
antibody, labeling was seen for photoreceptors as well as

cells scattered throughout the INL. The most intensely
labeled cells were in the region of the INL where most
of the amacrine cells reside. In culture we see widespread neuronal labeling with the most heavily labeled
cells always being amacrine cells. Because essentially all
cultured cells that normally reside in the INL showed
some labeling, we suggest that culturing somehow selects
for mGluR1-expressing neurons. There is no compelling
evidence that MuÈller glial cells label with this antibody
in the intact retina and consistent with this, glial cells
were not labeled in culture. The anti-mGluR5 antibody
labeled cell bodies and processes throughout the retina
and in agreement with this, both neuronal and glial cells
were labeled in culture. On the whole, a relatively normal
expression pattern of group I mGluRs is maintained in
culture.
Functional expression of group I mGluRs in cultured
amacrine cells
Our results indicate that cultured GABAergic amacrine cells
can express mGluR1 and mGluR5. The large fraction
(,95%) of amacrine cells in culture that label with both
antibodies implies that most, if not all, GABAergic
amacrine cells in culture express both group I mGluRs.
Because the amacrine cells in culture share so many
characteristics with mature GABAergic amacrine cells, we
expect that these cells will serve as a useful model system
for examining the function of group I mGluRs on
GABAergic amacrine cells in the intact retina. From the
Ca21 imaging experiments, we have obtained evidence
indicating that the group I receptors are functionally
expressed in cultured amacrine cells and, when activated,
can produce cytosolic Ca21 elevations, possibly through
linkage to the IP3 pathway. Duarte et al. (1996) reported that
ACPD was effective in stimulating inositol phospholipid
hydrolysis but not in elevating cytosolic Ca21. Our results
can be at least partially reconciled with theirs in that ACPD
was effective in elevating cytosolic Ca21 in a relatively
small fraction of amacrine cells (30%) and when observed,
the Ca21 elevations were always small relative to responses
elicited by DHPG in the same cell. Additionally, Duarte
et al. (1996) measured Ca21 from whole retinal cultures
rather than from individual amacrine cells, making small
and relatively rare responses more dif®cult to detect than in
our experiments, where we have measured ¯uorescence
from individual, identi®ed amacrine cells.
Our Ca21 imaging experiments also suggest that different
mGluR subtypes interact in complex ways. Our ability to
generate larger Ca21 elevations with more speci®c agonists
implies that coactivation of mGluRs results in interactions
between receptors and modi®cation of Ca21 responses. The
observation that antagonists of mGluR1 actually enhanced
agonist responses gives strength to this possibility. One
mechanism that could underlie the inhibitory activity of
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mGluR1 might be its activation of protein kinase C (Catania
et al. 1991; Aronica et al. 1993). Interestingly, it has been
demonstrated that protein kinase C activity can rapidly
desensitize mGluR5 (Gereau and Heinemann 1998). Alternatively, inhibitory interactions may occur downstream of
the receptor. One dif®culty in this system is that the
mGluR pharmacology has not been established for avian
receptors so we have based our interpretations on the
pharmacology of mammalian receptors. As such, some
caution must attend the interpretation of our results
until the avian receptors are cloned and individually
expressed.
If some mGluRs do modulate the function of other
mGluRs in amacrine cells, what might these interactions
mean in the context of the retina? We entertain two
possibilities. First, in the intact retina, mGluRs may be more
highly localized than they are on cells in culture. Indeed, the
laminar pattern of mGluR1 and 5 expression in the IPL is
consistent with this interpretation (see Figs 3 and 4).
Different mGluRs might be segregated in the amacrine cell
dendritic tree such that during a restricted local stimulation,
different receptor subtypes would not normally interact.
More global stimulation of the cell, however, might result in
interactions that modify the cellular response to mGluR
activation. Alternatively, coexpression of interacting
receptors might serve the special needs of a cell that is
post-synaptic to bipolar cells. The ability of bipolar cells to
produce sustained release of glutamate is likely to burden
post-synaptic amacrine cells with large Ca21 loads. Perhaps
inhibitory interactions between mGluRs represent a
protective mechanism that limits elevations in cytosolic
Ca21 but leaves other aspects of the signaling machinery
intact.
Our studies in the intact retina indicate that group I
mGluRs are expressed in multiple cell types, in the outer
plexiform layer, and in discrete synaptic layers in the inner
plexiform layer. Experiments on identi®ed GABAergic
amacrine cells in culture demonstrate that group I mGluRs
are functionally expressed and are linked to at least one
second messenger system. Elucidation of the activated
signaling pathways and their cellular targets in cultured
GABAergic amacrine cells may help us to unravel the
potentially complex role of glutamate as a modulator in the
inner retina.

Acknowledgements
We wish to thank Ron Bouchard for his assistance with the
microscopy and ®gures and David Lenzi for his critical
reading of this manuscript. This work was supported by
National Eye Institute Grant EY-12204 awarded to E. Gleason
and by a Howard Hughes Medical Institute Grant through
the Undergraduate Biological Sciences Education Program at
LSU.

References
Abe T., Sugihara H., Nawa H., Shigemoto R., Mizuno N. and
Nakanishi S. (1992) Molecular characterization of a novel
metabotropic glutamate receptor mGluR5 coupled to inositol
phosphate/Ca21 signal transduction. J. Biol. Chem. 267,
13361±13368.
Adler R., Magistretti P. J., Hyndman A. G. and Shoemaker W. J. (1982)
Puri®cation and cytochemical identi®cation of neuronal and nonneuronal cells in chick embryo retina cultures. Dev. Neurosci. 5,
27±39.
Adler R., Lindsey J. D. and Elsner C. L. (1984) Expression of cone-like
properties by chick embryo neural retina cells in glial-free
monolayer cultures. J. Cell Biol. 99, 1173±1178.
Araki M. and Kimura H. (1991) GABA-like immunoreactivity in the
developing chick retina: differentiation of GABAergic horizontal
cell and its possible contacts with photoreceptors. J. Neurocytol.
20, 345±355.
Aramori I. and Nakanishi S. (1992) Signal transduction and pharmacological characteristics of a metabotropic glutamate receptor,
mGluR1, in transfected CHO cells. Neuron 8, 757±765.
Aronica E., Dell'Albani P., Condorelli D. F., Nicoletti F. and Balazs R.
(1993) Mechanisms underlying developmental changes in the
expression of metabotropic glutamate receptors in cultured
cerebellar granule cells: homologous desensitization and interactive effects involving N-methyl-d-aspartate receptors. Mol.
Pharmacol. 44, 981±989.
Baskys A. and Malenka R. C. (1991) Agonists at metabotropic
glutamate receptors presynaptically inhibit EPSCs in neonatal
rat hippocampus. J. Physiol. (Lond.) 444, 687±701.
Brandon C. (1985) Retinal GABA neurons: localization in vertebrate
species using an antiserum to rabbit brain glutamate decarboxylase. Brain Res. 344, 286±295.
BrandstaÈtter J. H., Koulen P., Kuhn R., van der Putten H. and WaÈssle H.
(1996) Compartmental localization of a metabotropic glutamate
receptor (mGluR7): two different active sites at a retinal synapse.
J. Neurosci. 16, 4749±4756.
Bushell T. J., Lee C. C., Shigemoto R. and Miller R. J. (1999)
Modulation of synaptic transmission and differential localisation
of mGluRs in cultured hippocampal autapses. Neuropharmacology 38, 1553±1567.
Cai W. and Pourcho R. G. (1999) Localization of metabotropic
glutamate receptors mGluR1alpha and mGluR2/3 in the cat retina.
J. Comp. Neurol. 407, 427±437.
Catania M. V., Aronica E., Sortino M. A., Canonico P. L. and
Nicoletti F. (1991) Desensitization of metabotropic glutamate
receptors in neuronal cultures. J. Neurochem. 56, 1329±1335.
Chu Z. and Hablitz J. J. (1998) Activation of group I mGluRs increases
spontaneous IPSC frequency in rat frontal cortex. J. Neurophysiol.
80, 621±627.
Combes P. C., Privat A., Pessac B. and Calothy G. (1977)
Differentiation of chick embryo neuroretina cells in monolayer
cultures. An ultrastructural study. I. Seven-day retina. Cell Tissue
Res. 185, 159±173.
Conn P. J. and Pin J. P. (1997) Pharmacology and functions of
metabotropic glutamate receptors. Annu. Rev. Pharmacol. Toxicol.
37, 205±237.
Doherty A. J., Palmer M. J., Henley J. M., Collingridge G. L. and
Jane D. E. (1997) (R,S)-2-Chloro-5-hydroxyphenylglycine
(CHPG) activates mGlu5, but no mGlu1, receptors expressed in
CHO cells and potentiates NMDA responses in the hippocampus.
Neuropharmacology 36, 265±267.
Duarte C. B., Santos P. F. and Carvalho A. P. (1996) [Ca21]i regulation
by glutamate receptor agonists in cultured chick retina cells.
Vision Res. 36, 1091±1102.

q 2001 International Society for Neurochemistry, Journal of Neurochemistry, 77, 452±465

Retinal metabotropic glutamate receptors 465

Gafka A. C., Vogel K. S. and Linn C. L. (1999) Evidence of
metabotropic glutamate receptor subtypes found on cat®sh
horizontal and bipolar retinal neurons. Neuroscience 90,
1403±1414.
Gereau R. W. and Heinemann S. (1998) Role of protein kinase C
phosphorylation in rapid desensitization of metabotropic glutamate receptor 5. Neuron 20, 143±151.
Gleason E., Mobbs P., Nuccitelli R. and Wilson M. (1992) Development of functional calcium channels in cultured avian photoreceptors. Vis. Neurosci. 8, 315±327.
Gleason E., Borges S. and Wilson M. (1993) Synaptic transmission
between pairs of retinal amacrine cells in culture. J. Neurosci. 13,
2359±2370.
Godwin D. W., Vaughan J. W. and Sherman S. M. (1996) Metabotropic
glutamate receptors switch visual response mode of lateral
geniculate nucleus cells from burst to tonic. J. Neurophysiol. 76,
1800±1816.
Hartveit E., BrandstaÈtter J. H., Enz R. and WaÈssle H. (1995) Expression
of the mRNA of seven metabotropic glutamate receptors
(mGluR1±7) in the rat retina. An in situ hybridization study on
tissue sections and isolated cells. Eur. J. Neurosci. 7, 1472±1483.
Hayashi Y., Momiyama A., Takahashi T., Ohishi H., Ogawa-Meguro
R., Shigemoto R., Mizuno N. and Nakanishi S. (1993) Role of a
metabotropic glutamate receptor in synaptic modulation in the
accessory olfactory bulb. Nature 366, 687±690.
Huba R. and Hofmann H. D. (1990) Identi®cation of GABAergic
amacrine cell-like neurons developing in chick retinal monolayer
cultures. Neurosci. Lett. 117, 37±42.
Huba R. and Hofmann H. D. (1991) Transmitter-gated currents of
GABAergic amacrine-like cells in chick retinal cultures. Vis.
Neurosci. 6, 303±314.
Huba R., Schneider H. and Hofmann H. D. (1992) Voltage-gated
currents of putative GABAergic amacrine cells in primary cultures
and in retinal slice preparations. Brain Res. 577, 10±18.
Hyndman A. G. and Adler R. (1982) GABA uptake and release in
puri®ed neuronal and nonneuronal cultures from chick embryo
retina. Brain Res. 255, 167±180.
Jacoby R., Stafford D., Kouyama N. and Marshak D. (1996)
Synaptic inputs to ON parasol ganglion cells in the primate
retina. J. Neurosci. 16, 8041±8056.
Joly C., Gomeza J., Brabet I., Curry K., Bockaert J. and Pin J. P. (1995)
Molecular, functional, and pharmacological characterization of
the metabotropic glutamate receptor type 5 splice variants:
comparison with mGluR1. J. Neurosci. 15, 3970±3981.
Kalloniatis M. and Fletcher E. L. (1993) Immunocytochemical
localization of the amino acid neurotransmitters in the chicken
retina. J. Comp. Neuro. 336, 174±193.
Koulen P., Kuhn R., WaÈssle H. and BrandstaÈtter J. H. (1997) Group I
metabotropic glutamate receptors mGluR1alpha and mGluR5a:
localization in both synaptic layers of the rat retina. J. Neurosci.
17, 2200±2211.
Laemmli U. K. (1970) Cleavage of structural proteins during the
assembly of the head of bacteriophage T4. Nature 227, 680±685.
McCool B. A., Pin J. P., Harpold M. M., Brust P. F., Stauderman K. A.
and Lovinger D. M. (1998) Rat group I metabotropic glutamate
receptors inhibit neuronal Ca21 channels via multiple signal
transduction pathways in HEK 293 cells. J. Neurophysiol. 79,
379±391.
Martin L. J., Blackstone C. D., Huganir R. L. and Price D. L. (1992)
Cellular localization of a metabotropic glutamate receptor in rat
brain. Neuron 9, 259±270.
Masu M., Tanabe Y., Tsuchida K., Shigemoto R. and Nakanishi S.

(1991) Sequence and expression of a metabotropic glutamate
receptor. Nature 349, 760±765.
Masu M., Iwakabe H., Tagawa Y., Miyoshi T., Yamashita M., Fukuda
Y., Sasaki H., Hiroi K., Nakamura Y., Shigemoto R, Takada M.,
Nakamura K., Nukao K., Katsuki M. and Nakashini S. (1995)
Speci®c de®cit of the on response in visual transmission by
targeted disruption of the mGluR6 gene. Cell 80, 757±765.
Moroni F., Lombardi G., Thomsen C., Leonardi P., Attuci S.,
Peruginelli F., Torregrossa S. A., Pellegrini-Giampietro D. E.,
Luneia R. and Pellicciari R. (1997) Pharmacological characterization of 1-Aminiodan-1,5-dicarboxylic Acid, a potent mGluR1
antagonist. J. Pharm. Exp Therapeutics. 281, 721±729.
Mosinger J. L., Yazulla S. and Studholme K. M. (1986) GABA-like
immunoreactivity in the vertebrate retina: a species comparison.
Exp. Eye Res. 42, 631±644.
Nakajima Y., Iwakabe H., Akazawa C., Nawa H., Shegemoto R.,
Mizuno N. and Nakanishi S. (1993) Molecular characterization
of a novel retinal metabotropic glutamate receptor mGluR6 with
a high agonist selectivity for l-2-amino-4-phosphonobutyrate.
J. Biol. Chem. 268, 11868±11873.
Nurcombe V. and Bennett M. R. (1981) Embryonic chick retinal
ganglion cells identi®ed `in vitro'. Their survival is dependent on
a factor from the optic tectum. Exp. Brain Res. 44, 249±258.
Pin J. P., Waeber C., Prezeau L., Bockaert J. and Heinemann S. F.
(1992) Alternative splicing generates metabotropic glutamate
receptors inducing different patterns of calcium release in
Xenopus oocytes. Proc. Natl. Acad. Sci. USA 89, 10331±10335.
Poncer J. C., Shinozaki H. and Miles R. (1995) Dual modulation of
synaptic inhibition by distinct metabotropic glutamate receptors in
the rat hippocampus. J. Physiol. (Lond.) 485, 121±134.
Prada F. A., Chmielewski C. E., Dorado M. E., Prada C. and GenisGalvez J. M. (1989) Displaced ganglion cells in the chick retina.
Neurosci. Res. 6, 329±339.
Prezeau L., Gomeza J., Ahern S., Mary S., Galvez T., Bockaert J. and
Pin J. P. (1996) Changes in the carboxyl-terminal domain of
metabotropic glutamate receptor 1 by alternative splicing generate
receptors with differing agonist-independent activity. Mol.
Pharmacol. 49, 422±429.
Schoepp D. D., Jane D. E. and Monn J. A. (1999) Parmacological
agents acting at subtypes of metabotropic glutamate receptors.
Neuropharmacology 38, 1431±1476.
Vanselow J., Dutting D. and Thanos S. (1990) Target dependence of
chick retinal ganglion cells during embryogenesis: cell survival
and dendritic development. J. Comp. Neurol. 295, 235±247.
Vardi N. and Morigiwa K. (1997) ON cone bipolar cells in rat express
the metabotropic receptor mGluR6. Vis. Neurosci. 14, 789±794.
Vardi N., Morigiwa K., Wang T. L., Shi Y. J. and Sterling P. (1998)
Neurochemistry of the mammalian cone `synaptic complex'.
Vision Res. 38, 1998.
Vetter P., Garthwaite J. and Batchelor A. M. (1999) Regulation of
synaptic transmission in the mossy ®bre-granule cell pathway of
rat cerebellum by metabotropic glutamate receptors. Neuropharmacology 38, 805±815.
Wang Z. and McCormick D. A. (1993) Control of ®ring mode of
corticotectal and corticopontine layer V burst-generating neurons
by norepinephrine, acetylcholine, and 1S,3R- ACPD. J. Neurosci.
13, 2199±2216.
Xin D. and Bloom®eld S. A. (1997) Tracer coupling pattern of amacrine
and ganglion cells in the rabbit retina. J. Comp. Neurol. 383,
512±528.
Yang X. L. and Wu S. M. (1991) Coexistence and function of glutamate
receptor subtypes in the horizontal cells of the tiger salamander
retina. Vis. Neurosci. 7, 377±382.

q 2001 International Society for Neurochemistry, Journal of Neurochemistry, 77, 452±465

